Unibest

Pharmaceutical intermediates

Alfacalcidol Intermediates

2 pharmaceutical intermediates for Alfacalcidol. Indication: Vitamin D deficiency; Rickets; Osteoporosis; Hypoparathyroidism.

提交项目All intermediates

About Alfacalcidol

Originator
Leo Pharmaceutical Products Ltd
Indication
Vitamin D deficiency; Rickets; Osteoporosis; Hypoparathyroidism
Approved Date
01/01/1978

Available intermediates

2 intermediates currently listed for Alfacalcidol. Request specifications, documentation or a quotation for any item below.

Alfacalcidol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
[[(1a,3b,5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane]112670-85-6//
BRN 471587565445-14-9//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlogliptin/ Trelagliptin

Building toward Alfacalcidol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →